Tulane Home Tulane Shield logo linking to site home page

EDORA Trial

placeholder

The Effect of DrOnedarone on Atrial fibrillation progression and atrial fibrillation Recurrence post-Ablation (The EDORA Trial)

 

NCT: 04704050

Protocol ID: 2830294

Contact Information

Arezu Bhatnagar, MD, Clinical Project Manager
Tulane University School of Medicine - Academic Research Organization (ARO)

1440 Canal Street, Suite 1700, New Orleans, LA 70123
abhatnagar@tulane.edu and edoratrial@tulane.edu

504-988-6203